Primary cutaneous Ewing sarcoma: A systematic review focused on treatment and outcome

British Journal of Dermatology

Volumn 166, Issue 4, 2012, Pages 721-726

  Delaplace, M ^a   Lhommet, C ^a   De Pinieux, G ^a,b   Vergier, B ^c,d   De Muret, A ^a   MacHet, L ^a,b,e  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b UNIVERSITÉ DE TOURS   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e Université de Tours   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; EWING SARCOMA; HEMORRHAGIC CYSTITIS; HUMAN; LIVER VENOOCCLUSIVE DISEASE; MEDLINE; MORBIDITY; NEUROECTODERM TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY CUTANEOUS EWING SARCOMA; PRIMARY NEUROECTODERM TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOMA, EWING; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859159224     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10743.x     Document Type: Review

References (29)

1. Jedlicka P,. Ewing's sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. Int J Clin Exp Pathol 2010; 3: 338-47.
2. Balamuth NJ, Womer RB,. Ewing's sarcoma. Lancet Oncol 2010; 11: 184-92.
3. Esiashvili N, Goodman M, Marcus RB Jr,. Changes in incidence and survival of Ewing's sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol 2008; 30: 425-30.
4. Gupta AA, Pappo A, Saunders N, et al. Clinical outcome of children and adults with localized Ewing's sarcoma. Cancer 2010; 116: 3189-94.
5. Barnerjee SS, Agbamu DA, Eyden BP, et al. Clinicopathological characteristics of peripheral primitive neuroectodermal tumour of skin and subcutaneous tissue. Histopathology 1997; 31: 355-66.
6. Hasegawa SL, Davidson JM, Rutten A, et al. Primary cutaneous Ewing's sarcoma. Immunophenotypic and molecular cytogenetic evaluation of five cases. Am J Surg Pathol 1998; 22: 310-18.
7. Chow E, Merchant TE, Pappo A, et al. Cutaneous and subcutaneous Ewing's sarcoma: an indolent disease. Int J Radiat Oncol Biol Phys 2000; 46: 433-8.
8. Ehrig T, Billings SD, Fanburg-Smith JC,. Superficial primitive neuroectodermal tumor/Ewing's sarcoma (PN/ES): same tumor as deep PN/ES or new entity? Ann Diagn Pathol 2007; 11: 153-9.
9. Terrier-Lacombe MJ, Guillou L, Chibon F, et al. Superficial primitive Ewing's sarcoma: a clinicopathologic and molecular cytogenetic analyses of 14 cases. Mod Pathol 2009; 22: 87-94.
10. Shingde MV, Buckland M, Busam KJ, et al. Primary cutaneous Ewing's sarcoma/primitive neuroectodermal tumour: a clinicopathological analysis of seven cases highlighting diagnostic pitfalls and the role of FISH testing in diagnosis. J Clin Pathol 2009; 62: 915-19.
11. Somers GR, Shago M, Zielenska M, et al. Primary subcutaneous primitive neuroectodermal tumor with aggressive behavior and an unusual karyotype: case report. Pediatr Dev Pathol 2004; 7: 538-45.
12. Meyer WH, Kun LE, Marina N, et al. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. J Clin Oncol 1992; 10: 1737-42.
13. Marina NM, Pappo AS, Parham DM, et al. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St Jude Children's Research Hospital. J Clin Oncol 1999; 17: 180-90.
14. Shamberger RC, LaQuaglia MP, Gebhardt MC, et al. Ewing's sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 2003; 238: 563-7.
15. Cotteril SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European intergroup cooperative Ewing's Sarcoma study group. J Clin Oncol 2000; 18: 3108-14.
16. Ladenstein R, Pötschger U, Le Deley MC, et al. Primary disseminated multifocal Ewing's sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol 2010; 28: 3284-91.
17. Ahmad R, Mayol BR, Davis M, et al. Extraskeletal Ewing's sarcoma. Cancer 1999; 85: 725-31.
18. Krasin M, Davidoff A, Rodriguez-Galindo C, et al. Definitive surgery and multiagent systemic therapy for patients with localized Ewing sarcoma family of tumors. Cancer 2005; 104: 367-73.
19. Baldini EH, Demetri GD, Fletcher CD, et al. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome. Ann Surg 1999; 230: 79-86.
20. Bahk WJ, Chang ED, Bae JM, et al. Primary cutaneous Ewing's sarcoma/primitive neuroectodermal tumor manifesting numerous small and huge ulcerated masses: its complete remission by chemotherapy and magnetic resonance imaging findings. Skeletal Radiol 2010; 39: 595-600.
21. Dogan S, Lekovic G, Theodore N, et al. Primary thoracolumbar Ewing's sarcoma presenting as isolated epidural mass. Spine J 2009; 9: 9-14.
22. Paoletti H, Colineau X, Acalet L, et al. Extraosseous Ewing sarcoma, report of 3 cases and review of the literature. J Radiol 1999; 80: 477-82.
23. Mukhopadhyay P, Gairola M, Sharma MC, et al. Primary spinal epidural extraosseous Ewing's sarcoma: report of five cases and literature review. Australas Radiol 2001; 45: 372-9.
24. Marec-Bérard P, Chotel F, Claude L,. PNET/Ewing tumours: current treatments and future perspectives. Bull Cancer 2010; 97: 707-13.
25. Juergens C, Weston C, Lewis I, et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin and etoposide (VIDE) in the treatment of Ewing tumors in the EOR-EWING 99 clinical trial. Pediatr Blood Cancer 2006; 47: 22-9.
26. Inskip PD, Curtis RE,. New malignancies following childhood cancer in the United States, 1973-2002. Int J Cancer 2007; 121: 2233-40.
27. Ginsberg JP, Goodman P, Leisenring W, et al. Long-term survivors of childhood Ewing's sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst 2010; 102: 1272-83.
28. Fagnou C, Michon J, Peter M, et al. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique. J Clin Oncol 1998; 16: 1707-11.
29. Zoubek A, Ladenstein R, Windhager R, et al. Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluation. Int J Cancer 1998; 79: 56-60.